Showing 1 - 3 results of 3 for search 'Robert Pordy', query time: 0.01s Refine Results
  1. 1
    Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

    Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials by Antonio J. Vallejo‐Vaz, Henry N. Ginsberg, Michael H. Davidson, Robert H. Eckel, Christopher P. Cannon, L. Veronica Lee, Laurence Bessac, Robert Pordy, Alexia Letierce, Kausik K. Ray

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES

    Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES by Gregory P. Geba, Ruifeng Chen, Kasturi Talapatra, Taylor Brackin, Kusha A. Mohammadi, Robert Pordy, Garen Manvelian, David J. Maron, Gregory G. Schwartz, Michael Szarek, Ph. Gabriel Steg, Sergio Fazio

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial

    GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial by Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, Shazia Ali, Prodromos Parasoglou, Anita Boyapati, Kusha Mohammadi, Bret J. Musser, Pretty Meier, Jason Mastaitis, Mark W. Sleeman, David J. Glass, Evelyn Gasparino, Jesus Trejos, John D. Davis, Boaz Hirshberg, Robert Pordy, George D. Yancopoulos, Gary A. Herman

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: